Arcadia Biosciences Stock Price, News & Analysis (NASDAQ:RKDA)

$0.21 0.00 (0.00 %)
(As of 12/11/2017 04:00 PM ET)
Previous Close$0.21
Today's Range$0.20 - $0.23
52-Week Range$0.19 - $1.50
Volume185,530 shs
Average Volume192,774 shs
Market Capitalization$8.79 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.31

About Arcadia Biosciences (NASDAQ:RKDA)

Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market. Its crop yield traits are utilized by its partners to develop higher yielding seeds for global crops, including wheat, rice, soybean, corn, and sugarcane, as well as for other crops, such as cotton, turf and trees. The Company's portfolio of agricultural productivity traits includes Nitrogen Use Efficiency (NUE), Water Use Efficiency (WUE), Drought Tolerance (DT), Salinity Tolerance (ST) and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada.

Receive RKDA News and Ratings via Email

Sign-up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Agricultural Chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNASDAQ:RKDA
CUSIPN/A
Phone530-756-7077

Debt

Debt-to-Equity RatioN/A
Current Ratio6.81%
Quick Ratio6.72%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$3.19 million
Price / Sales2.81
Cash FlowN/A
Price / CashN/A
Book Value$0.50 per share
Price / Book0.42

Profitability

Trailing EPS($0.43)
Net Income$-19,620,000.00
Net Margins-588.11%
Return on Equity-111.88%
Return on Assets-41.80%

Miscellaneous

Employees57
Outstanding Shares42,680,000

Arcadia Biosciences (NASDAQ:RKDA) Frequently Asked Questions

What is Arcadia Biosciences' stock symbol?

Arcadia Biosciences trades on the NASDAQ under the ticker symbol "RKDA."

How were Arcadia Biosciences' earnings last quarter?

Arcadia Biosciences, Inc. (NASDAQ:RKDA) announced its quarterly earnings data on Wednesday, May, 10th. The basic materials company reported ($0.10) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.07) by $0.03. The basic materials company earned $1.02 million during the quarter. Arcadia Biosciences had a negative return on equity of 111.88% and a negative net margin of 588.11%. View Arcadia Biosciences' Earnings History.

Where is Arcadia Biosciences' stock going? Where will Arcadia Biosciences' stock price be in 2017?

1 equities research analysts have issued 12 month target prices for Arcadia Biosciences' stock. Their predictions range from $1.00 to $1.00. On average, they anticipate Arcadia Biosciences' share price to reach $1.00 in the next year. View Analyst Ratings for Arcadia Biosciences.

Who are some of Arcadia Biosciences' key competitors?

Who are Arcadia Biosciences' key executives?

Arcadia Biosciences' management team includes the folowing people:

  • Kevin J. Comcowich, Chairman of the Board (Age 49)
  • Rajendra Dinkar Ketkar, President, Chief Executive Officer, Director (Age 62)
  • Steven F. Brandwein, Interim Chief Financial Officer (Age 60)
  • Donald L Emlay, Vice President - Regulatory Affairs and Compliance (Age 73)
  • Zhongjin Lu, Vice President - Product Development
  • Peter Gajdos, Director (Age 32)
  • Eric J. Rey, Director
  • Gregory D. Waller, Director (Age 67)
  • Amy J. Yoder, Director (Age 50)
  • Uday Garg, Independent Director (Age 36)

When did Arcadia Biosciences IPO?

(RKDA) raised $66 million in an initial public offering on Friday, May 15th 2015. The company issued 8,200,000 shares at a price of $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray served as the underwriters for the IPO.

How do I buy Arcadia Biosciences stock?

Shares of Arcadia Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Arcadia Biosciences' stock price today?

One share of Arcadia Biosciences stock can currently be purchased for approximately $0.21.

How big of a company is Arcadia Biosciences?

Arcadia Biosciences has a market capitalization of $8.79 million and generates $3.19 million in revenue each year. The basic materials company earns $-19,620,000.00 in net income (profit) each year or ($0.43) on an earnings per share basis. Arcadia Biosciences employs 57 workers across the globe.

How can I contact Arcadia Biosciences?

Arcadia Biosciences' mailing address is 202 COUSTEAU PLACE SUITE 105, DAVIS CA, 85018. The basic materials company can be reached via phone at 530-756-7077 or via email at [email protected]


MarketBeat Community Rating for Arcadia Biosciences (RKDA)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  40 (Vote Outperform)
Underperform Votes:  28 (Vote Underperform)
Total Votes:  68
MarketBeat's community ratings are surveys of what our community members think about Arcadia Biosciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Arcadia Biosciences (NASDAQ:RKDA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyBuyBuy
Consensus Rating Score: 2.002.502.502.50
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $1.00$1.00$1.00$1.00
Price Target Upside: 96.08% upside96.08% upside96.08% upside25.00% upside

Arcadia Biosciences (NASDAQ:RKDA) Consensus Price Target History

Price Target History for Arcadia Biosciences (NASDAQ:RKDA)

Arcadia Biosciences (NASDAQ:RKDA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/22/2017Piper Jaffray CompaniesSet Price TargetHold$1.00MediumView Rating Details
6/2/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
(Data available from 12/11/2015 forward)

Earnings

Arcadia Biosciences (NASDAQ:RKDA) Earnings History and Estimates Chart

Earnings by Quarter for Arcadia Biosciences (NASDAQ:RKDA)

Arcadia Biosciences (NASDAQ RKDA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/10/2017Q2 2017($0.11)($0.09)$0.99 millionViewN/AView Earnings Details
5/10/2017Q1 2017($0.07)($0.10)$1.02 millionViewN/AView Earnings Details
3/8/2017Q4 2016($0.10)($0.13)$0.54 millionViewListenView Earnings Details
11/10/2016Q316($0.07)($0.09)$2.10 million$1.08 millionViewListenView Earnings Details
8/9/2016Q216($0.07)($0.10)$1.90 million$0.72 millionViewListenView Earnings Details
5/10/2016Q116($0.07)($0.12)$1.60 million$0.85 millionViewListenView Earnings Details
3/8/2016Q415($0.07)($0.09)$2.40 million$1.35 millionViewListenView Earnings Details
11/5/2015Q315($0.07)($0.11)$2.40 million$1.82 millionViewN/AView Earnings Details
8/10/2015Q215($0.11)($0.19)$2.90 million$1.43 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Arcadia Biosciences (NASDAQ:RKDA) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.4 EPS
Next Year EPS Consensus Estimate: $-0.24 EPS

Dividends

Dividend History for Arcadia Biosciences (NASDAQ:RKDA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Arcadia Biosciences (NASDAQ RKDA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 25.90%
Institutional Ownership Percentage: 9.90%
Insider Trades by Quarter for Arcadia Biosciences (NASDAQ:RKDA)

Arcadia Biosciences (NASDAQ RKDA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/17/2017Zhongjin LuVPSell5,950$0.23$1,368.50View SEC Filing  
6/8/2017Eric J ReyDirectorBuy5,000$0.75$3,750.00View SEC Filing  
8/4/2016Roger SalamehCOOSell100$2.51$251.00View SEC Filing  
6/13/2016Steven F BrandweinInsiderSell8,280$2.49$20,617.20View SEC Filing  
4/25/2016Steven F BrandweinInsiderSell1,720$2.42$4,162.40View SEC Filing  
4/5/2016Vic C KnaufInsiderSell2,853$2.98$8,501.94View SEC Filing  
3/4/2016Vic C KnaufInsiderSell3,273$3.20$10,473.60View SEC Filing  
2/3/2016Eric J. ReyCEOSell3,200$2.92$9,344.00View SEC Filing  
2/1/2016Vic C. KnaufinsiderSell1,666$3.00$4,998.00View SEC Filing  
12/15/2015Steven F. BrandweininsiderSell10,035$3.57$35,824.95View SEC Filing  
12/2/2015Vic C. KnaufinsiderSell15,000$4.01$60,150.00View SEC Filing  
11/11/2015Vic C. KnaufinsiderSell4,527$2.91$13,173.57View SEC Filing  
10/9/2015Eric J. ReyCEOSell5,145$3.01$15,486.45View SEC Filing  
10/8/2015Eric J. ReyCEOSell9,100$3.13$28,483.00View SEC Filing  
10/5/2015Eric J. ReyCEOSell21,636$3.07$66,422.52View SEC Filing  
9/30/2015Eric J. ReyCEOSell15,900$3.46$55,014.00View SEC Filing  
9/25/2015Eric J. ReyCEOSell21,089$4.27$90,050.03View SEC Filing  
9/14/2015Don EmlayVPSell3,521$4.95$17,428.95View SEC Filing  
9/11/2015Zhongjin LuVPSell1,068$4.92$5,254.56View SEC Filing  
9/10/2015Vic C. KnaufinsiderSell6,840$5.50$37,620.00View SEC Filing  
9/10/2015Zhongjin LuVPSell6,672$5.48$36,562.56View SEC Filing  
5/20/2015Terri C BishopMajor ShareholderBuy1,000,000$8.00$8,000,000.00View SEC Filing  
5/20/2015Uday GargDirectorBuy375,000$8.00$3,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Arcadia Biosciences (NASDAQ RKDA) News Headlines

Source:
DateHeadline
Davis-based Arcadia Biosciences names new chairman, after previous chairmans deathDavis-based Arcadia Biosciences names new chairman, after previous chairman's death
finance.yahoo.com - November 23 at 8:13 AM
Edited Transcript of RKDA earnings conference call or presentation 9-Nov-17 9:30pm GMTEdited Transcript of RKDA earnings conference call or presentation 9-Nov-17 9:30pm GMT
finance.yahoo.com - November 12 at 12:23 PM
Arcadia Biosciences Announces Date of Third-Quarter 2017 Financial Results and Business Highlights Conference CallArcadia Biosciences Announces Date of Third-Quarter 2017 Financial Results and Business Highlights Conference Call
finance.yahoo.com - October 27 at 2:40 PM
ETFs with exposure to Arcadia Biosciences, Inc. : October 27, 2017ETFs with exposure to Arcadia Biosciences, Inc. : October 27, 2017
finance.yahoo.com - October 27 at 2:40 PM
How Much Money Does Arcadia Biosciences Inc (RKDA) Have Left?How Much Money Does Arcadia Biosciences Inc (RKDA) Have Left?
finance.yahoo.com - October 6 at 6:57 AM
Arcadia Biosciences To Accelerate Agricultural Trait Development with CRISPR-Cas9Arcadia Biosciences To Accelerate Agricultural Trait Development with CRISPR-Cas9
finance.yahoo.com - September 12 at 9:18 AM
Arcadia Biosciences to Present at the Credit Suisse 30th Annual Basic Materials Conference on September 13, 2017Arcadia Biosciences to Present at the Credit Suisse 30th Annual Basic Materials Conference on September 13, 2017
finance.yahoo.com - September 7 at 8:26 AM
Arcadia Biosciences to Participate in Rodman & Renshaw 19th Annual Global Investment Conference on September 12, 2017Arcadia Biosciences to Participate in Rodman & Renshaw 19th Annual Global Investment Conference on September 12, 2017
finance.yahoo.com - September 6 at 7:40 AM
ETFs with exposure to Arcadia Biosciences, Inc. : September 1, 2017ETFs with exposure to Arcadia Biosciences, Inc. : September 1, 2017
finance.yahoo.com - September 1 at 8:03 AM
Arcadia Biosciences, Inc. :RKDA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017Arcadia Biosciences, Inc. :RKDA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 26 at 8:52 AM
Arcadia Biosciences (RKDA) Says FDA Publishes Final Rule Amending Food Regulations for Use of SONOVA GLA Safflower Oil in Dog FoodArcadia Biosciences (RKDA) Says FDA Publishes Final Rule Amending Food Regulations for Use of SONOVA GLA Safflower Oil in Dog Food
www.streetinsider.com - August 16 at 7:17 AM
US FDA Publishes Final Rule Amending Food Regulations for Use of SONOVA® GLA Safflower Oil in Dog FoodUS FDA Publishes Final Rule Amending Food Regulations for Use of SONOVA® GLA Safflower Oil in Dog Food
finance.yahoo.com - August 16 at 7:17 AM
Edited Transcript of RKDA earnings conference call or presentation 10-Aug-17 8:30pm GMTEdited Transcript of RKDA earnings conference call or presentation 10-Aug-17 8:30pm GMT
finance.yahoo.com - August 12 at 7:24 AM
Arcadia Biosciences, Inc. (RKDA) Issues Quarterly  Earnings ResultsArcadia Biosciences, Inc. (RKDA) Issues Quarterly Earnings Results
www.americanbankingnews.com - August 11 at 12:24 PM
Arcadia Biosciences (RKDA) JV Verdeca Announces FDA Completed Safety Review of its HB4 Stress-Tolerant SoybeansArcadia Biosciences (RKDA) JV Verdeca Announces FDA Completed Safety Review of its HB4 Stress-Tolerant Soybeans
www.streetinsider.com - August 11 at 8:04 AM
Arcadia Biosciences Announces Second-Quarter and First-Half 2017 Financial Results and Business HighlightsArcadia Biosciences Announces Second-Quarter and First-Half 2017 Financial Results and Business Highlights
www.businesswire.com - August 11 at 8:04 AM
Amy Yoder Joins Arcadia Biosciences Board Of DirectorsAmy Yoder Joins Arcadia Biosciences Board Of Directors
finance.yahoo.com - August 10 at 7:25 AM
Arcadia Biosciences, Inc. (RKDA) Set to Announce Quarterly Earnings on MondayArcadia Biosciences, Inc. (RKDA) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - July 31 at 8:16 AM
Arcadia Biosciences Announces Date of Second-Quarter 2017 Financial Results and Business Highlights Conference CallArcadia Biosciences Announces Date of Second-Quarter 2017 Financial Results and Business Highlights Conference Call
finance.yahoo.com - July 28 at 7:22 AM
Piper Jaffray Companies Analysts Give Arcadia Biosciences, Inc. (NASDAQ:RKDA) a $1.00 Price TargetPiper Jaffray Companies Analysts Give Arcadia Biosciences, Inc. (NASDAQ:RKDA) a $1.00 Price Target
www.americanbankingnews.com - July 23 at 10:40 PM
Arcadia Biosciences’ Water Use Efficiency Trait Completes US Food and Drug Administration Early Food Safety EvaluationArcadia Biosciences’ Water Use Efficiency Trait Completes US Food and Drug Administration Early Food Safety Evaluation
finance.yahoo.com - July 20 at 7:17 AM
Arcadia Biosciences (RKDA) Appoints Eric Rey & Gregory Waller to BoardArcadia Biosciences (RKDA) Appoints Eric Rey & Gregory Waller to Board
www.streetinsider.com - June 14 at 12:40 AM
Arcadia Biosciences misses by $0.03, misses on revenueArcadia Biosciences misses by $0.03, misses on revenue
seekingalpha.com - May 12 at 1:02 AM
ARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
us.rd.yahoo.com - March 9 at 8:13 AM
Q4 2016 Arcadia Biosciences Inc Earnings Release - After Market CloseQ4 2016 Arcadia Biosciences Inc Earnings Release - After Market Close
biz.yahoo.com - March 8 at 8:42 AM
Origin, Arcadia Announce China Biotechnology Collaboration in CornOrigin, Arcadia Announce China Biotechnology Collaboration in Corn
au.finance.yahoo.com - February 22 at 9:35 AM
Study Shows Arcadia’s Nitrogen Use Efficiency Trait Increases Yield in NERICA RiceStudy Shows Arcadia’s Nitrogen Use Efficiency Trait Increases Yield in NERICA Rice
au.finance.yahoo.com - February 15 at 12:55 AM
Arcadia Biosciences Obtains U.S. FDA GRAS Status for SONOVA ® GLA Safflower OilArcadia Biosciences Obtains U.S. FDA GRAS Status for SONOVA ® GLA Safflower Oil
www.businesswire.com - January 11 at 8:48 PM
Arcadia Biosciences (RKDA) SONOVA GLA Safflower Oil Gains Generally Recognized as Safe Status from FDAArcadia Biosciences (RKDA) SONOVA GLA Safflower Oil Gains 'Generally Recognized as Safe' Status from FDA
www.streetinsider.com - January 11 at 8:48 PM
BRIEF-Arcadia Biosciences terminates chief legal officers jobBRIEF-Arcadia Biosciences terminates chief legal officer's job
www.reuters.com - December 8 at 8:01 PM
Arcadia Biosciences to Participate in UBS...Arcadia Biosciences to Participate in UBS...
www.benzinga.com - December 5 at 7:25 PM
ARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal OfficersARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - November 9 at 7:11 PM
ARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh
biz.yahoo.com - September 8 at 6:45 PM
Arcadia Biosciences posts larger loss in first quarter under new CEOArcadia Biosciences posts larger loss in first quarter under new CEO
www.bizjournals.com - August 10 at 10:15 AM
Q2 2016 Arcadia Biosciences Inc Earnings Release - After Market CloseQ2 2016 Arcadia Biosciences Inc Earnings Release - After Market Close
biz.yahoo.com - August 9 at 10:20 AM
ARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or SARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S
biz.yahoo.com - July 22 at 4:01 PM
ARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial StatARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Stat
biz.yahoo.com - July 14 at 4:42 PM
ARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a VARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a V
biz.yahoo.com - June 10 at 3:01 PM
6 Biggest Mid-Day Movers6 Biggest Mid-Day Movers
www.benzinga.com - June 2 at 10:09 AM
Davis biosciences firm names Monsanto veteran as CEODavis biosciences firm names Monsanto veteran as CEO
www.bizjournals.com - May 11 at 9:51 AM
ARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or PARCADIA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or P
biz.yahoo.com - May 10 at 4:48 PM
Q1 2016 Arcadia Biosciences Inc Earnings Release - After Market CloseQ1 2016 Arcadia Biosciences Inc Earnings Release - After Market Close
biz.yahoo.com - May 10 at 7:07 AM

SEC Filings

Arcadia Biosciences (NASDAQ:RKDA) SEC Filings

DateFilerForm TypeView

Social Media

Financials

Arcadia Biosciences (NASDAQ:RKDA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Arcadia Biosciences (NASDAQ RKDA) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.